Tarceva

Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players

Motley Fool

FDA fast tracks two new lung cancer drugs

FDA fast tracks two new lung cancer drugs

PM Live

Lung Cancer Genomic Mapping Yields New Targets, Researchers Say

Lung Cancer Genomic Mapping Yields New Targets, Researchers Say

Bloomberg

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib

Motley Fool

Bayer says Nexavar-Tarceva trial unsuccessful

Bayer says Nexavar-Tarceva trial unsuccessful

Reuters

Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without their disease getting worse

Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without their disease getting worse

Pipeline Review

Roche’s Tarceva Stalls Lung Cancer in Late-Stage Study

Roche’s Tarceva Stalls Lung Cancer in Late-Stage Study

Yahoo/AP

Roche Tarceva Drug's Use in Lung Cancer Predicted in Cancer Cell Genes

Roche Tarceva Drug's Use in Lung Cancer Predicted in Cancer Cell Genes

Bloomberg

News

Astellas, Partners Reach Settlement With Teva on Tarceva Patent

Bloomberg

News

Roche’s Tarceva Extends Lives, Study Stopped Early

Bloomberg